Page 342 - Multidisipliner Covid 19

BÖLÜM 21

KAYNAKLAR

1. Zhang L, Shen FM,Chen F, Lin Z. Origin and Evolution of the 2019
Novel Coronavirus. Clin Inf Dis. 2020:ciaa112.
2. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus
Disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720
3. World Healt Organization (WHO). Novel Coronavirus (2019-nCoV)
Situation Report-29 (18 February 2020).Geneva, Switzerland: World
Healt Organization; 2020.
4. World Healt Organization (WHO). Coronavirus Disease 2019 (COVID-
19), Situation Report-63.
5. Lai CC, Shih TP, Ko WC, Tang HJ,Hsueh PR. Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS CoV-2) and Coronavirus Disease2019
(COVİD-19): The Epidemic and the Challenges. Int J Antimicrob Agents
2020;105924.
6. Van Doremalen N, Morris DH, Holbrook MG, Gamble A, Wlliamson
BN et al. Aerosol and surface stablity of SARS-CoV-2 as comparedwith
SARS-CoV-1. N Eng J Med.2020.
7. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses
on inanimate surface and their inactivation with biocidal agents. JHosp
Infect. 2020;104:246-251.
8. Team TNCPERE (2020). The Epidemiological Characteristics of an Out-
break of 2019 Novel Coronavirus Disease (COVID-19). China CDC
Weekly 2020.
9. Coran VM, Muth D, Niemeyer D, Drosten C. Hosts and Sources of En-
demic Human Coronaviruses. Adv Virus Res. 2018;100:163-188.
10. Loon SC, Teoh SCB, Oon LLE et al. The Severe Acute Respiratory Syn-
drome Coronavirus in Tears. British J Ophthalmol. 2004;88 (7): 861-863.
11. Yeo C, Kaushal S, Yeo D. Enteric İnvolvement OF Coronaviruses: İs
Faecal and Oral Transmission of SARS-CoV-2 Possible? Lancet Gastro-
enterol Hepatol. 2020.
12. Hung LS. The SARS Epidemic in Hong Kong: What Lessons Have
We Learned? J R Soc Med. 2003;96(8):374-378.
13. Van der Hoek L, Pyrc K, Jebbink MF et al. Identification of a New Hu-
man Coronavirus. Nat Med. 2004;10(4):368-373.
14. Vabret A, Mourez T, Dina J et al. Human Coronavirus NL63, France.
Emerg Infect Dis.2005;11(8):1225-1229.

341